Oncogenic signalling crosstalk between MYD88 and CD79B mutations

Researchers

  • Dr Keisuke Horikawa (Primary Investigator)

Grant status

Completed

Grant start date

01/01/2019

Grant funding

  • 2019: $269,462 from National Health and Medical Research Council (NHMRC)
  • 2020: $284,462 from National Health and Medical Research Council (NHMRC)
  • 2021: $294,462 from National Health and Medical Research Council (NHMRC)

Updated:  20 April 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers